Clinical Trials Directory

Trials / Conditions / T-cell Acute Lymphoblastic Leukemia/Lymphoma

T-cell Acute Lymphoblastic Leukemia/Lymphoma

4 registered clinical trials studyying T-cell Acute Lymphoblastic Leukemia/Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingAnti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
NCT06934382
Stephan Grupp MD PhDPhase 1
RecruitingClinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
NCT05626400
Hebei Senlang Biotechnology Inc., Ltd.N/A
WithdrawnDonor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphom
NCT05487495
Beijing Boren HospitalPhase 1
CompletedCell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specifi
NCT04572308
Hebei Senlang Biotechnology Inc., Ltd.Phase 1